China Market Update: Meituan Receives Outsized Mainland Flow, Week In Review
CLN
KraneShares
Asian equities ended a positive week mixed, led by India following a larger-than-expected rate cut (0.50% vs. 0.25%). South Korea was closed for Memorial Day, and Indonesia, Pakistan, and the Philippines were closed for Eid al-Adha, also known as the Feast of Sacrifice, 'a festival to honor the willingness of the Prophet Ibrahim to follow the command of Allah to sacrifice his son.'
Hong Kong and Mainland China saw profit taking in recent growth and technology outperformers despite the Trump-Xi call, as some pointed to a lack of details, though President Trump confirmed the US would be represented by Bessent, Lutnick, and Greer at a yet-to-be-determined location. The markets had risen on the chatter of a call in another example of markets' forward-looking nature, i.e., buy the rumor and sell the news.
Short-video platform Kuaishou Technology gained +8.44% as the company announced its Kling AI, an AI online video generator, will generate $100 million in revenue by February of 2026.
E-commerce names, including Alibaba and JD.com, which fell -1.44% and -1.45%, as several provinces, including Jiangsu and Chongqing, announced they had run out of home appliance subsidies to be used in the 618 (June 18) E-Commerce sales event. I suspect the issue will be resolved in short order.
Electric vehicle (EV) stocks, including BYD, which fell -2.18%, Xiaomi, which fell -2.12%, Li Auto, which was flat, and XPeng, which fell -1.77%, were mostly lower on yesterday's news of the Ministry of Industry and Information Technology's (MIIT) price war warning. It seems like a positive to me!
Value plays such as telecom and precious metals outperformed. Mainland investors bought the dip in Hong Kong, with $862 million worth of net buying via Southbound Stock Connect. Meituan saw another day of strong net inflow, as 13.54% of shares are now held by Mainland investors, up from only 11% earlier this year. I don't know what's driving Mainland investors' significant Meituan inflows, at 200 million shares bought, but it is interesting. Like Hong Kong, value stocks outperformed growth stocks in Shanghai and Shenzhen, as oil, precious metals, and aerospace stocks rallied.
May's consumer price index (CPI) and producer price index (PPI) will be reported on Sunday.
The US Treasury did not label China a currency manipulator, though it does highlight the strength of the Renminbi versus the US dollar, recently. CNY hit a low of 7.34 CNY per USD on April 9th following Liberation Day, though CNY has rallied to 7.18 (CNY is quoted USD per CNY, so a decline is appreciation versus the US dollar). More surprising is that Hong Kong and US-listed China stocks haven't rallied more due to the appreciation of the underlying businesses, as their revenues are denominated in Renminbi. Hopefully, we'll see this move soon!
New Content
Read our latest article:
Navigating Global Crosswinds: Carbon Markets Respond to Tariff Tactics and Executive Orders
Please click here to read
Chart1
KraneShares
Chart2
KraneShares
Chart3
KraneShares
Chart4
KraneShares
Chart5
KraneShares
Chart6
KraneShares
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Is this the Tesla stock buying opportunity I've been waiting for?
Down by 22% in little over a week, Tesla (NASDAQ:TSLA) sometimes seems to be behaving more like a penny share than a company worth almost $900bn that last year had a revenue close to $100bn. Still, I have been eyeing Tesla stock as a possible addition to my portfolio for a while already – so could this latest crash offer me the sort of buying opportunity I have been hoping for? My answer depends on the price, something I will get into below. First, though, I ought to explain why I like the idea of owning some Tesla stock at all. The company is barely more than two decades old. But it has already built up a massive global manufacturing and sales footprint for its electric vehicles. Sales volumes declined slightly last year (and that decline has accelerated this year), but remain substantial. I think Tesla's recent history points to two important factors. First, it is a serious contender in the electric vehicle space. That is a competitive area and Tesla risks rivals like BYD leaving it behind, but it has strengths such as proprietary technology, a vertically integrated business model and unique designs. A second point also jumps out at me from Tesla's development. It has demonstrated expertise not only in imagining new products, but in bringing them to market at scale and quickly. It is doing the same now with its power storage division, which, unlike the car business, had a very strong first quarter. Such expertise could help Tesla capitalize on some of the other ideas that sit somewhere between its drawing board and widespread real world use, from automated taxi fleets to robotics. That matters because, seen purely as a car company, Tesla stock would look wildly overvalued to me. As far as I am concerned, the only possible justification for the current valuation, let alone a higher one, is the potential of the company's plans beyond the electric car business. That, however, is where I start to have serious concerns about valuation, even after the recent crash in Tesla stock. While the power storage business is growing quickly, even taken together with the car business I do not think the joint valuation ought to be anywhere close to $900bn. Meanwhile, the other ideas are highly speculative for now – it remains to be seen when they are commercialized at scale, if they ever are. So I think it is hard to justify anything more than a fairly modest valuation for them at this point, no matter how large the long-term potential may seem to be. Taken as the sum of the parts, I do not think Tesla is worth anything like its market capitalization. So, although the share is cheaper than a couple of weeks back, it is still far too expensive for me to consider buying yet. The post Is this the Tesla stock buying opportunity I've been waiting for? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
an hour ago
- Associated Press
Tianci International, Inc. Reports Third Quarter 2025 Financial Results
HONG KONG, HK / ACCESS Newswire / June 7, 2025 / Tianci International, Inc. (the 'Company' or 'Tianci'), a global logistics service provider specializing in ocean freight forwarding, announced its financial results for the three and nine months ended April 30, 2025. Third Quarter 2025 Highlights: About Tianci International, Inc. Tianci International Inc., through its subsidiary Roshing, provides global logistics services specializing in ocean freight forwarding, including container and bulk goods shipping. Operating under an asset-light model, Roshing's logistics solutions are tailored to meet the diverse needs of its customers across the Asia-Pacific, including Japan, South Korea, and Vietnam. Beyond logistics, the company generates revenue from the sale of electronic parts and business consulting services. The company's mission is to provide customers with efficient, reliable, and safe shipping services that create value. For more information, please visit the Company's website: Forward-Looking Statements Certain statements in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. The Company encourages investors to review other factors that may affect its future results that are discussed in the Company's filings with the U.S. Securities and Exchange Commission. Contact Information Michael Yip [email protected] SOURCE: Tianci International Inc. press release
Entrepreneur
2 hours ago
- Entrepreneur
Biopeak Raises USD 3.5 Million to Expand AI-Driven Health Clinics
"We're at a unique point where developments in molecular diagnostics, AI, and imaging allow us to understand the human body in unprecedented ways," says Rishi Pardal, Co-founder and CEO of Biopeak Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Biopeak, a wellness and longevity-focused startup headquartered in Bengaluru, has raised USD 3.5 million (approximately INR 29 crore) in seed funding from a group of notable investors. The round saw participation from Accel founding partner Prashanth Prakash, Claypond Capital--the family office of Manipal Group chairman Ranjan Pai and NKSquared, the investment arm of Zerodha co-founder Nikhil Kamath. Founded in 2024 by Rishi Pardal and Shiva Subramanian, Biopeak delivers personalised health services through its own clinics, combining advanced diagnostics, molecular science, and artificial intelligence (AI) to monitor early signs of physiological change. The company launched its first clinic in Bengaluru in March 2025. The funding will be used to expand Biopeak's clinic footprint across key Indian cities and strengthen its AI-based diagnostic and care delivery platform. "We're at a unique point where developments in molecular diagnostics, AI, and imaging allow us to understand the human body in unprecedented ways," said Rishi Pardal, Co-founder and CEO of Biopeak. "Our platform translates these insights into actionable, individualised health plans aimed at extending one's healthspan, not just lifespan." Biopeak's approach includes a suite of diagnostic tools such as microbiome mapping, organic acid profiling, salivary cortisol rhythm analysis, and whole-exome functional genomics. These are integrated with non-invasive imaging technologies including MRI, CT, DXA, and ECHO, along with tissue-level screenings to assess toxin levels, mineral balance, and oxidative stress. Clients typically undergo more than six hours of detailed consultations guided by a dedicated health manager and a multidisciplinary team of specialists. Health plans are updated regularly based on follow-up tests and consultations. Commenting on the investment, Prashanth Prakash said, "As India's population ages, our challenge is to build systems that not only extend life but also improve the quality of those extended years. Geroscience, early interventions, and scalable healthcare models will be central to this shift." Prakash, who also mentors Biopeak, is the Founding Patron of Longevity India, a platform focused on ageing research and interventions tailored for India's demographic needs.
